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April 20111164 Letters to the Editorinterventions are likely to be most effective in this challenging
setting.
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Regarding “An analysis of relationship between
quality of life indices and clinical improvement
following intervention in patients with intermittent
claudication due to femoropopliteal disease”
We would like to complement Dr Mazari et al1 for their strict
follow-up and large sample size in their study of correlation be-
tween quality of life (QoL) instruments and clinical improvement
following intervention in patients with intermittent claudication
(IC) due to superficial femoral artery disease.
The study was presented as a prospective observational study
of patients recruited from an ongoing randomized controlled trial
(RCT) comparing supervised exercise, angioplasty, and combined
therapy with data reported until 12 months after the intervention.
To our surprise, this manuscript referred to the exact same
group of 178 patients as mentioned in their article published
previously this year, on the 1-month and 3-month follow-up of
clinical and QoL outcomes of their well performed RCT compar-
ing the three interventions.2
Although the current article includes the 12-month follow-up
assessments, it does not show us the results of the clinical and QoL
outcomes by allocated intervention, which is much more relevant
for clinical practice.
This is a missed opportunity because long-term follow-up in a
large group of patients with IC randomized in three different inter-
ventions has not been performed before, the studies in this field are
scarce and we would actually like to know what the most optimal
treatment strategy is for a patient with IC. Also, because only one
former publication focused on patients with IC due solely to femoro-
popliteal artery disease (comparing two interventions; supervised ex-
ercise with combined therapy) and they were unable to give a clear
answer owing to low recruitment rate and low rate of eligibility.3
In conclusion, QoL index scores are evidently an appropriate
tool for independent outcome reporting following interventions
for IC, but we do not see the newsworthiness of reporting QoL
changes after all interventions together. Despite our comment, we
certainly look forward to the long-term results of this study initi-
ated by the Academic Vascular Surgery Unit of the University of
Hull (http://ClinicalTrials.gov identifier: NCT00798850).
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We appreciate and welcome the comments made by Dr Frans
nd Dr Koelemay regarding our article and would like to address
he issues they raised, one by one:
First, we clearly mentioned in the Methods section that this
as an observational study that recruited patients from an ongoing
andomized controlled trial (RCT). This is the largest RCT to date
n claudicant patients with femoropopliteal disease and has many
ubsidiary studies running alongside. Because the study under
onsideration was purely observational, no sample size calculations
ere performed, and we aimed to maximize the recruitment to get
eliable and robust results. In this particular instance, all trial
articipants consented to take part in the study and were included
n the final analysis.
Second, there is a dearth of studies reporting the relationship
etween quality-of-life (QOL) indexes and clinical indicators, as
entioned in the introduction and in the Discussion section.
ecause these indexes are commonly used in economic analyses, it
s important to study and establish their relationship, and the study
as conducted to answer this specific question in all treatment
roups. Therefore, subgroup analysis was not performed as a part
f this study. Furthermore, subgroup analysis of QOL indicators is
ncluded in the results of the RCT and, therefore, cannot be
resented in this particular article.
Third, the findings of this study provide evidence to use
omposite outcome measures, including clinical and QOL indica-
ors in future studies, regardless of the treatments. This, in our
iew, was worthy of reporting to the scientific community. This
iew was clearly shared by our peers who reviewed the manuscript
nd found it worthy of publication in this esteemed journal.
And finally, the final results of the RCT are currently under
eview for publication, and we hope that they will provide the
nswers that Dr Frans and Dr Koelemay are looking for.
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he Swedish experience of screening for abdominal
ortic aneurysm
Ruptured abdominal aortic aneurysm (AAA) is a common
ause of death among elderly men. Early detection by screening
ith ultrasound and prophylactic surgery in appropriately selected
